TWD 70.7
(-3.42%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 138.8 Million TWD | 9.27% |
2022 | 127.02 Million TWD | -13.28% |
2021 | 146.47 Million TWD | -7.25% |
2020 | 157.91 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q1 | 122.72 Million TWD | -11.59% |
2024 Q2 | 131.5 Million TWD | 7.16% |
2023 Q2 | 127.16 Million TWD | 11.1% |
2023 FY | 138.8 Million TWD | 9.27% |
2023 Q1 | 114.46 Million TWD | 0.0% |
2023 Q4 | 138.8 Million TWD | 4.43% |
2023 Q3 | 132.91 Million TWD | 4.52% |
2022 Q4 | - TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Allied Biotech Corporation | 601.47 Million TWD | 76.922% |
GeneFerm Biotechnology Co., Ltd. | 155.43 Million TWD | 10.697% |
Easywell Biomedicals, Inc. | 42.17 Million TWD | -229.153% |
TTY Biopharm Company Limited | 1.09 Billion TWD | 87.335% |
Synmosa Biopharma Corporation | 1.59 Billion TWD | 91.315% |
Orient EuroPharma Co., Ltd. | 1.09 Billion TWD | 87.333% |
Center Laboratories, Inc. | 269.22 Million TWD | 48.443% |
Tien Liang BioTech Co., Ltd. | 75.79 Million TWD | -83.132% |
Orient Pharma Co., Ltd. | 233.97 Million TWD | 40.674% |
InnoPharmax Inc. | 22.24 Million TWD | -524.048% |
Excelsior Biopharma Inc. | 217.28 Million TWD | 36.116% |
DV Biomed Co., Ltd. | 96.51 Million TWD | -43.819% |
Foresee Pharmaceuticals Co., Ltd. | 126.79 Million TWD | -9.47% |
Handa Pharmaceuticals, Inc. | - TWD | -Infinity% |
UniPharma Co., Ltd. | 28.94 Million TWD | -379.571% |
Anxo Pharmaceutical Co., Ltd. | 283.86 Million TWD | 51.1% |
Alar Pharmaceuticals Inc. | - TWD | -Infinity% |
Winston Medical Supply Co., Ltd. | 115.73 Million TWD | -19.934% |
Mercury Biopharmaceutical Corporation | 10.07 Million TWD | -1277.874% |
Bioray Biotech Co., Ltd | 55.95 Million TWD | -148.091% |
TSH Biopharm Corporation Limited | 118.39 Million TWD | -17.241% |